Obese children (age: 7 to 16 y) are at higher risk of having reflux symptoms compared with the control group. This risk is independent of age, sex, or race and increases with higher BMI.
system particularly with regard to timeliness of stent removal and incidence of retained or missed stents.CONCLUSIONS: Our integrated stent tracking system embedded within EPIC is a feasible mechanism for potentially reducing the incidence of retained stents while adding minimal administrative and financial burden on the surgeon and hospital. Current studies are ongoing to assess the efficacy of our system at preventing retained stents.
ORIGINAL PROF-3362 ABSTRACT… Objectives: To determine the frequency and clinical pattern of mass in right iliac fossa. Study Design: Cross sectional multicenter study. Period: One year (from 03 March 2014 to 02 March 2015). Setting: Patients with right iliac fossa mass of >11 years of and of either gender admitted in department of surgery at Liaquat university hospital Hyderabad / Jamshoro and Peoples University Hospital Nawabshah. Patients and methods: The data was analyzed in SPSS 16 and the frequency and percentage was calculated. Results: During one year study period, out of 227 patients, 112 subjects were observed to have right iliac fossa mass due to different etiologies, of which 82(73.2%) were males and 30 (26.8%) were females. The mean age ±SD for overall population was 39.32±8.66 while it was 37.88±6.75 and 38.93±7.72 in male and female population respectively. The male population was predominant while the patterns observed were appendicular mass in 19(17%), appendicular abscess in 26(23.21%), ileocaecal tuberculosis in 38(34%), carcinoma caecum in 14(12.5%), psoas abscess in 5(4.46%) and others in 10(9%) respectively. Conclusion: The highest incidence of mass in the right iliac fossa was seen in second, third and four decades with male population predominance. The common disorders identified were ileocaecal tuberculosis, appendicular mass and abscess and carcinoma caecum respectively Key words:Right iliac fossa mass, appendicular mass, appendicular abscess, ileocaecal tuberculosis, tuberculosis, carcinoma caecum and psoas abscess. NTRODUCTIONThe mass in the abdomen has wide spread implications and since long exercised the minds of many researchers and health care providers.
Objective: Over bearing, appendectomies have continuously been pushing the surgical wisdom to connote on non-operative option of treatment so this study was designed with an objective to assess the outcomes of antibiotics as primary therapy for un-complicated acute appendicitis. Methods: A total of 96 patients of both genders from 16 to 60 years of age having uncomplicated acute appendicitis enrolled in this study were treated with antibiotics and were discharged on third day with having oral treatment on ciprofloxacin (500mg) twice a day and metronidazole (400mg) thrice a day for 07 days. Routine follow up was taken on days 15, 30, 90 180 and 360 and outcomes were recorded. Results: Among 96 patients, 10 (10.41%) worsened in symptoms (pain on visual analogue scale) were confirmed with WBC & Ultrasound reports and under went for appendectomies during initial hospital stay. While within 9 months, during follow up 11 (11.45%) patients were readmitted in hospital and operated after confirmation on re-examination and re-investigations. Total of 21 (22%) patients were subjected to appendectomy. Conclusion: Under proper observation, antibiotic treatment can be safe and effective in un-complicated acute appendicitis with reduced recurrence.
Background and ObjectiveDouble J (JJ) ureteric stenting represents one of the most significant causes of patient discomfort and dissat-isfaction following endourological procedures. At our institution, a large tertiary referral centre for complex stones, standard JJ stent removal was previously undertaken with a flexible cystoscope (FC) in the endoscopy department by a doctor. The pathway was prone to delays through capacity constraints and prioritization being given to cancer investigations. The Isiris® is a single-use stent removal system consisting of a ‘camera on chip’ disposable FC with an integrated grasper. We examine the feasibility of a nurse-led stent removal service using Isiris®, performed as an office-based procedure, and its effect on waiting times. Material and MethodsA specialist stone nurse undertook training in FC approved by the British Association of Urological Surgeons (BAUS) and the British Association of Urological Nurses (BAUN). Once competency was reached, a nurse-led service was offered to patients in the outpatient setting. A prospective database from April 2018 to March 2020 was maintained to include patient data for stent removals in the nurse-led clinic using Isiris®. This was compared to a retrospective dataset of FC and stent removal between July 2016 and December 2016, per-formed by a doctor in the endoscopy department. The delays in stent removal compared to the ‘ideal’ stent removal date (planned date plus or minus 3 days tolerance allowed) were compared between the two pathways. ResultsThe specialist nurse undertook BAUS theory training and competency was reached using an approved BAUS/BAUN competency package. 414 stent removals were booked in the nurse group, of which 395 were undertaken. 291 of 395 (74%) patients in the nurse removal Isiris® group had their stent removed on time, whereas only 16 of 54 (30%) patients had their stents removed on time in the FC stent removal group. A delay of more than 21 days was seen in 22% of FC group vs only 2% in the nurse-led Isiris® group. Both planned removal and actual stent dwell time were longer in the FC group compared to Isiris® group (p < 0.0001). There were no major complications with the use of Isiris® for stent removal in the nurse-led clinic. ConclusionThis study has demonstrated that it is feasible to introduce a nurse-led stent removal service. The introduction of this service using the Isiris® system has led to a reduction in delays of stent removal, which is likely to trans-late into significant quality of life improvement for patients and economic benefits for the healthcare system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.